Evidence map›Paper›PMID 35779441›Full record

ArticleRedox biology2022

Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.

Yingying Chen, Ting Zhang, Shaoxue Zeng, Rong Xu, Kaiyu Jin, Nathan J Coorey, Yekai Wang, Ke Wang, So-Ra Lee, Michelle Yam and 7 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Yingying ChenDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
Ting ZhangSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia. Electronic address: ting.zhang@sydney.edu.au.
Shaoxue ZengSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
Rong XuDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, 26506, United States; Department of Biochemistry, West Virginia University, Morgantown, WV, 26506, United States.
Kaiyu JinPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Nathan J CooreyCanberra Health Services, Canberra, ACT, 2601, Australia.
Yekai WangDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, 26506, United States; Department of Biochemistry, West Virginia University, Morgantown, WV, 26506, United States.
Ke WangKey Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province, 214063, China.
So-Ra LeeSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
Michelle YamSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
Meidong ZhuSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia; New South Wales Tissue Bank, Sydney Eye Hospital, New South Wales Organ and Tissue Donation Service, Sydney, NSW, 2000, Australia.
Andrew ChangSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
Xiaohui FanSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia; Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Meixia ZhangDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Macular Disease Research Laboratory, Department of Ophthalmology, Sichuan University, West China Hospital, Chengdu, Sichuan, 610041, China.
Jianhai DuDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, 26506, United States; Department of Biochemistry, West Virginia University, Morgantown, WV, 26506, United States.
Mark C GilliesSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
Ling ZhuSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2000, Australia.
The University of Sydney · AUWest Virginia University · USAct Health · AUSichuan University · CNZhejiang University · CN

Funding

Retinal Mitochondrial Metabolism in Alzheimer's DiseaseR01EY031324 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2024
$2.0M
Proline metabolism in retinal healthR01EY032462 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2025
$1.9M
NEI NIH HHS R01 EY031324NEI NIH HHS R01 EY032462
6 · The paper itself

Abstract

The Pentose Phosphate Pathway (PPP), a metabolic offshoot of the glycolytic pathway, provides protective metabolites and molecules essential for cell redox balance and survival. Transketolase (TKT) is the critical enzyme that controls the extent of "traffic flow" through the PPP. Here, we explored the role of TKT in maintaining the health of the human retina. We found that Müller cells were the primary retinal cell type expressing TKT in the human retina. We further explored the role of TKT in human Müller cells by knocking down its expression in primary cultured Müller cells (huPMCs), isolated from the human retina (11 human donors in total), under light-induced oxidative stress. TKT knockdown and light stress reduced TKT enzymatic activities and the overall metabolic activities of huPMCs with no detectable cell death. TKT knockdown restrained the PPP traffic flow, reduced the expression of NAD(P)H Quinone Dehydrogenase 1 (NQO1), impaired the antioxidative response of NRF2 to light stress and aggravated the endoplasmic reticulum (ER) stress. TKT knockdown also inhibited overall glucose intake, reduced expression of Dihydrolipoamide dehydrogenase (DLD) and impaired the energy supply of the huPMCs. In summary, Müller cell-mediated TKT activity plays a critical protective role in the stressed retina. Knockdown of TKT disrupted the PPP and impaired overall glucose utilisation by huPMCs and rendered huPMCs more vulnerable to light stress by impairing energy supply and antioxidative NRF2 responses.

Indexed as

NF-E2-Related Factor 2TransketolaseEpendymoglial CellsGlucoseHumansPentose Phosphate PathwayPentosesPhosphatesGlucoseNF-E2-Related Factor 2PentosesPhosphatesTransketolaseMüller cellsNQO1NRF2Oxidative stressPentose phosphate pathwayTransketolase (TKT)

Identifiers

PMID35779441
PMCPMC9287732
OpenAlexW4283455030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.